Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3200405 | Journal of Allergy and Clinical Immunology | 2009 | 8 Pages |
Abstract
Increased BMI is not associated with clinically significant worsening of impairment in subjects with mild-to-moderate persistent asthma. There is a modest association between increased BMI and reduced therapeutic effect of ICS-containing regimens in this patient population. Prospective studies evaluating the effect of being overweight or obese on treatment response in asthma are warranted.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
E. Rand MD, MPH, Erik B. MS, Mihaela MD, MS, Michael E. MD, MMSc, National Heart, Lung, and Blood Institute's Asthma Clinical Research Network National Heart, Lung, and Blood Institute's Asthma Clinical Research Network,